Cargando…
The pharmacology and therapeutic role of cannabidiol in diabetes
In recent years, cannabidiol (CBD), a non‐psychotropic cannabinoid, has garnered substantial interest in drug development due to its broad pharmacological activity and multi‐target effects. Diabetes is a chronic metabolic disease that can damage multiple organs in the body, leading to the developmen...
Autores principales: | Zhang, Jin, Lin, Cong, Jin, Sha, Wang, Hongshuang, Wang, Yibo, Du, Xiubo, Hutchinson, Mark R., Zhao, Huiying, Fang, Le, Wang, Xiaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582612/ https://www.ncbi.nlm.nih.gov/pubmed/37933286 http://dx.doi.org/10.1002/EXP.20230047 |
Ejemplares similares
-
Regulatory Status of Cannabidiol in the United States: A Perspective
por: Corroon, Jamie, et al.
Publicado: (2018) -
Targeting cannabidiol to specific areas of the brain: an ultrasound-based strategy
por: Branca, Jacopo Junio Valerio, et al.
Publicado: (2020) -
Pharmacological strategies for treating misfolded rhodopsin-associated autosomal dominant retinitis pigmentosa
por: Xi, Yibo, et al.
Publicado: (2021) -
Cannabidiol preferentially binds TRPV2: a novel mechanism of action
por: Landucci, Elisa, et al.
Publicado: (2022) -
A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans
por: Nahler, Gerhard, et al.
Publicado: (2017)